200 related articles for article (PubMed ID: 31843268)
1. A lipopolysaccharide-free outer membrane vesicle vaccine protects against Acinetobacter baumannii infection.
Pulido MR; García-Quintanilla M; Pachón J; McConnell MJ
Vaccine; 2020 Jan; 38(4):719-724. PubMed ID: 31843268
[TBL] [Abstract][Full Text] [Related]
2. Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection.
García-Quintanilla M; Pulido MR; Pachón J; McConnell MJ
PLoS One; 2014; 9(12):e114410. PubMed ID: 25485716
[TBL] [Abstract][Full Text] [Related]
3. Immunization with lipopolysaccharide-free outer membrane complexes protects against Acinetobacter baumannii infection.
Pulido MR; García-Quintanilla M; Pachón J; McConnell MJ
Vaccine; 2018 Jul; 36(29):4153-4156. PubMed ID: 29887323
[TBL] [Abstract][Full Text] [Related]
4. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii.
McConnell MJ; Rumbo C; Bou G; Pachón J
Vaccine; 2011 Aug; 29(34):5705-10. PubMed ID: 21679737
[TBL] [Abstract][Full Text] [Related]
5. Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection.
Huang W; Wang S; Yao Y; Xia Y; Yang X; Li K; Sun P; Liu C; Sun W; Bai H; Chu X; Li Y; Ma Y
Sci Rep; 2016 Nov; 6():37242. PubMed ID: 27849050
[TBL] [Abstract][Full Text] [Related]
6. Immunological evaluation of OMV(PagL)+Bap(1-487aa) and AbOmpA(8-346aa)+Bap(1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection.
Badmasti F; Ajdary S; Bouzari S; Fooladi AA; Shahcheraghi F; Siadat SD
Mol Immunol; 2015 Oct; 67(2 Pt B):552-8. PubMed ID: 26277277
[TBL] [Abstract][Full Text] [Related]
7. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection.
Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N
Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813
[TBL] [Abstract][Full Text] [Related]
8. OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections.
Huang W; Wang S; Yao Y; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Ma Y
Vaccine; 2015 Aug; 33(36):4479-85. PubMed ID: 26207591
[TBL] [Abstract][Full Text] [Related]
9. Immunogenic reactivity of recombinant PKF and AbOmpA proteins as serum resistance factors against sepsis of Acinetobacter baumannii.
Bolourchi N; Shahcheraghi F; Shirazi AS; Janani A; Bahrami F; Badmasti F
Microb Pathog; 2019 Jun; 131():9-14. PubMed ID: 30930220
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice.
KuoLee R; Harris G; Yan H; Xu HH; Conlan WJ; Patel GB; Chen W
Vaccine; 2015 Jan; 33(1):260-7. PubMed ID: 24699469
[TBL] [Abstract][Full Text] [Related]
11. Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models.
Huang W; Yao Y; Long Q; Yang X; Sun W; Liu C; Jin X; Li Y; Chu X; Chen B; Ma Y
PLoS One; 2014; 9(6):e100727. PubMed ID: 24956279
[TBL] [Abstract][Full Text] [Related]
12. Development of Different Methods for Preparing
Li S; Chen DQ; Ji L; Sun S; Jin Z; Jin ZL; Sun HW; Zeng H; Zhang WJ; Lu DS; Luo P; Zhao AN; Luo J; Zou QM; Li HB
Front Immunol; 2020; 11():1069. PubMed ID: 32655550
[No Abstract] [Full Text] [Related]
13. Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection.
Ainsworth S; Ketter PM; Yu JJ; Grimm RC; May HC; Cap AP; Chambers JP; Guentzel MN; Arulanandam BP
Vaccine; 2017 Jun; 35(26):3387-3394. PubMed ID: 28522011
[TBL] [Abstract][Full Text] [Related]
14. Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen.
Bottero D; Zurita ME; Gaillard ME; Bartel E; Vercellini C; Hozbor D
Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29180369
[No Abstract] [Full Text] [Related]
15. Vesicle-Mediated Dendritic Cell Activation in
Cai W; Kesavan DK; Cheng J; Vasudevan A; Wang H; Wan J; Abdelaziz MH; Su Z; Wang S; Xu H
J Immunol Res; 2019; 2019():2835256. PubMed ID: 32083139
[No Abstract] [Full Text] [Related]
16. Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii.
Huang W; Yao Y; Wang S; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Chu X; Bai H; Yao Y; Ma Y
Sci Rep; 2016 Feb; 6():20724. PubMed ID: 26853590
[TBL] [Abstract][Full Text] [Related]
17. Outer membrane vesicles generated by an exogenous bacteriophage lysin and protection against Acinetobacter baumannii infection.
Li C; Xue H; Du X; Nyaruaba R; Yang H; Wei H
J Nanobiotechnology; 2024 May; 22(1):273. PubMed ID: 38773507
[TBL] [Abstract][Full Text] [Related]
18. Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine.
McConnell MJ; Pachón J
Vaccine; 2010 Dec; 29(1):1-5. PubMed ID: 21044668
[TBL] [Abstract][Full Text] [Related]
19. Protective response against
Ramezanalizadeh F; Rasooli I; Owlia P
Future Microbiol; 2021 Feb; 16(3):143-157. PubMed ID: 33528272
[No Abstract] [Full Text] [Related]
20. Outer-Membrane-Vesicle-Associated O Antigen, a Crucial Component for Protecting Against
Bottero D; Zurita ME; Gaillard ME; Carriquiriborde F; Martin Aispuro P; Elizagaray M; Bartel E; Castuma C; Hozbor D
Front Immunol; 2018; 9():2501. PubMed ID: 30459769
[No Abstract] [Full Text] [Related]
[Next] [New Search]
